Published in Am J Respir Cell Mol Biol on January 19, 2006
The airway epithelium: soldier in the fight against respiratory viruses. Clin Microbiol Rev (2011) 2.05
Bronchial mucosal inflammation and upregulation of CXC chemoattractants and receptors in severe exacerbations of asthma. Thorax (2007) 1.77
A Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids. Br J Pharmacol (2007) 1.71
Human rhinovirus 1B exposure induces phosphatidylinositol 3-kinase-dependent airway inflammation in mice. Am J Respir Crit Care Med (2008) 1.67
Thymic stromal lymphopoietin gene promoter polymorphisms are associated with susceptibility to bronchial asthma. Am J Respir Cell Mol Biol (2010) 1.39
CXCR2 is required for neutrophilic airway inflammation and hyperresponsiveness in a mouse model of human rhinovirus infection. J Immunol (2009) 1.28
RSV-induced bronchial epithelial cell PD-L1 expression inhibits CD8+ T cell nonspecific antiviral activity. J Infect Dis (2011) 1.03
The role of combination therapy with corticosteroids and long-acting beta2-agonists in the prevention of exacerbations in COPD. Int J Chron Obstruct Pulmon Dis (2006) 0.88
Effects of β(2) Agonists, Corticosteroids, and Novel Therapies on Rhinovirus-Induced Cytokine Release and Rhinovirus Replication in Primary Airway Fibroblasts. J Allergy (Cairo) (2011) 0.86
Virus infection-induced bronchial asthma exacerbation. Pulm Med (2012) 0.86
Budesonide and formoterol reduce early innate anti-viral immune responses in vitro. PLoS One (2011) 0.85
Updates in the relationship between human rhinovirus and asthma. Allergy Asthma Immunol Res (2011) 0.85
Budesonide and formoterol effects on rhinovirus replication and epithelial cell cytokine responses. Respir Res (2013) 0.84
Glucocorticosteroids enhance replication of respiratory viruses: effect of adjuvant interferon. Sci Rep (2014) 0.84
Rhinovirus-16 induced release of IP-10 and IL-8 is augmented by Th2 cytokines in a pediatric bronchial epithelial cell model. PLoS One (2014) 0.78
The calcitonin and glucocorticoids combination: mechanistic insights into their class-effect synergy in experimental arthritis. PLoS One (2013) 0.78
Tulobuterol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells. Physiol Rep (2013) 0.77
Basic research on virus-induced asthma exacerbation: inhibition of inflammatory chemokine expression by fluticasone propionate. Int Arch Allergy Immunol (2013) 0.77
Models of Respiratory Infections: Virus-Induced Asthma Exacerbations and Beyond. Allergy Asthma Immunol Res (2015) 0.77
Understanding how long-acting β2 -adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma - an update. Br J Pharmacol (2016) 0.77
Cistrome-based Cooperation between Airway Epithelial Glucocorticoid Receptor and NF-κB Orchestrates Anti-inflammatory Effects. J Biol Chem (2016) 0.77
Anti-inflammatory effects of the novel inhaled phosphodiesterase type 4 inhibitor CHF6001 on virus-inducible cytokines. Pharmacol Res Perspect (2016) 0.75
Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med (2005) 6.05
Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med (2006) 5.90
Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol (2007) 4.54
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med (2006) 4.11
Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med (2011) 3.58
IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med (2014) 3.32
Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med (2003) 3.32
Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci U S A (2008) 3.12
Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet (2002) 3.11
The September epidemic of asthma exacerbations in children: a search for etiology. J Allergy Clin Immunol (2005) 2.87
Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med (2010) 2.85
Association of bacteria and viruses with wheezy episodes in young children: prospective birth cohort study. BMJ (2010) 2.65
Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat Med (2008) 2.44
Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life: a birth cohort study. Pediatr Infect Dis J (2006) 2.44
Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med (2004) 2.40
Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 2.28
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2014) 2.17
Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ (2002) 2.14
Detection of airborne rhinovirus and its relation to outdoor air supply in office environments. Am J Respir Crit Care Med (2004) 2.13
Asthma exacerbations: origin, effect, and prevention. J Allergy Clin Immunol (2011) 2.09
Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 2.06
Personal exposure to nitrogen dioxide (NO2) and the severity of virus-induced asthma in children. Lancet (2003) 1.96
Increased interleukin-4, interleukin-5, and interferon-gamma in airway CD4+ and CD8+ T cells in atopic asthma. Am J Respir Crit Care Med (2004) 1.88
Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med (2012) 1.85
Local CD11c+ MHC class II- precursors generate lung dendritic cells during respiratory viral infection, but are depleted in the process. J Immunol (2006) 1.83
Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog (2010) 1.82
Rhinovirus viremia in children with respiratory infections. Am J Respir Crit Care Med (2005) 1.78
Rhinovirus-induced interferon production is not deficient in well controlled asthma. Thorax (2013) 1.77
Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease. Pharmacol Ther (2008) 1.74
The role of viruses in acute exacerbations of asthma. J Allergy Clin Immunol (2010) 1.71
Human rhinovirus 1B exposure induces phosphatidylinositol 3-kinase-dependent airway inflammation in mice. Am J Respir Crit Care Med (2008) 1.67
Rhinovirus infection increases 5-lipoxygenase and cyclooxygenase-2 in bronchial biopsy specimens from nonatopic subjects. J Infect Dis (2002) 1.59
Toll-like receptor 3 is induced by and mediates antiviral activity against rhinovirus infection of human bronchial epithelial cells. J Virol (2005) 1.52
PMA induces the MUC5AC respiratory mucin in human bronchial epithelial cells, via PKC, EGF/TGF-alpha, Ras/Raf, MEK, ERK and Sp1-dependent mechanisms. J Mol Biol (2004) 1.51
How viral infections cause exacerbation of airway diseases. Chest (2006) 1.48
The September epidemic of asthma hospitalization: school children as disease vectors. J Allergy Clin Immunol (2006) 1.48
Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 1.40
Rhinovirus 16-induced IFN-α and IFN-β are deficient in bronchoalveolar lavage cells in asthmatic patients. J Allergy Clin Immunol (2012) 1.35
IFN-gamma-induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbations. J Allergy Clin Immunol (2007) 1.34
Etiology of asthma exacerbations. J Allergy Clin Immunol (2008) 1.31
Frequency of detection of picornaviruses and seven other respiratory pathogens in infants. Pediatr Infect Dis J (2005) 1.28
Respiratory syncytial virus persistence in chronic obstructive pulmonary disease. Pediatr Infect Dis J (2008) 1.26
Host defense function of the airway epithelium in health and disease: clinical background. J Leukoc Biol (2003) 1.24
Expression of programmed death-1 ligand (PD-L) 1, PD-L2, B7-H3, and inducible costimulator ligand on human respiratory tract epithelial cells and regulation by respiratory syncytial virus and type 1 and 2 cytokines. J Infect Dis (2005) 1.23
An experimental model of rhinovirus induced chronic obstructive pulmonary disease exacerbations: a pilot study. Respir Res (2006) 1.22
Microbes and mucosal immune responses in asthma. Lancet (2013) 1.20
The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity. Nat Med (2013) 1.20
The microbiology of asthma. Nat Rev Microbiol (2012) 1.14
Detection of exacerbations in asthma based on electronic diary data: results from the 1-year prospective BIOAIR study. Thorax (2013) 1.13
The effect of inhaled IFN-β on worsening of asthma symptoms caused by viral infections. A randomized trial. Am J Respir Crit Care Med (2014) 1.11
Rhinovirus replication in human macrophages induces NF-kappaB-dependent tumor necrosis factor alpha production. J Virol (2006) 1.11
Mouse respiratory epithelial cells support efficient replication of human rhinovirus. J Gen Virol (2003) 1.10
Defining critical roles for NF-κB p65 and type I interferon in innate immunity to rhinovirus. EMBO Mol Med (2012) 1.08
Rhinovirus infections: more than a common cold. Am J Respir Crit Care Med (2006) 1.08
Air pollution and infection in respiratory illness. Br Med Bull (2003) 1.07
The role of IL-15 deficiency in the pathogenesis of virus-induced asthma exacerbations. PLoS Pathog (2011) 1.05
Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma. Pulm Pharmacol Ther (2002) 1.04
Influenza infection and COPD. Int J Chron Obstruct Pulmon Dis (2007) 1.04
Diagnosis of pathogens in exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc (2007) 1.04
The emerging role of microRNAs in regulating immune and inflammatory responses in the lung. Immunol Rev (2013) 1.03
RSV-induced bronchial epithelial cell PD-L1 expression inhibits CD8+ T cell nonspecific antiviral activity. J Infect Dis (2011) 1.03
Echinacea in the prevention of induced rhinovirus colds: a meta-analysis. Clin Ther (2006) 1.03
Role of viral infections, atopy and antiviral immunity in the etiology of wheezing exacerbations among children and young adults. Pediatr Infect Dis J (2005) 1.03
Lung microbiology and exacerbations in COPD. Int J Chron Obstruct Pulmon Dis (2012) 1.01
The role of antibiotics in asthma. Int J Antimicrob Agents (2007) 1.00
Corticosteroids and beta2 agonists differentially regulate rhinovirus-induced interleukin-6 via distinct Cis-acting elements. J Biol Chem (2007) 0.97
Role of interleukin-1 and MyD88-dependent signaling in rhinovirus infection. J Virol (2011) 0.97
New paradigms in the pathogenesis of chronic obstructive pulmonary disease II. Proc Am Thorac Soc (2009) 0.97
Increased proinflammatory responses from asthmatic human airway smooth muscle cells in response to rhinovirus infection. Respir Res (2006) 0.96
Pathogenesis of respiratory syncytial virus bronchiolitis-related wheezing. Paediatr Respir Rev (2004) 0.96
Airborne rhinovirus detection and effect of ultraviolet irradiation on detection by a semi-nested RT-PCR assay. BMC Public Health (2003) 0.96
Cross-serotype immunity induced by immunization with a conserved rhinovirus capsid protein. PLoS Pathog (2013) 0.96
Viruses in asthma. Br Med Bull (2002) 0.95
Viruses exacerbating chronic pulmonary disease: the role of immune modulation. BMC Med (2012) 0.95
Reducing agents inhibit rhinovirus-induced up-regulation of the rhinovirus receptor intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells. FASEB J (2002) 0.94
Cough and viruses in airways disease: mechanisms. Pulm Pharmacol Ther (2009) 0.94
Molecular mechanisms of respiratory virus-induced asthma and COPD exacerbations and pneumonia. Curr Med Chem (2006) 0.93
Retracted Impaired type I and type III interferon induction and rhinovirus control in human cystic fibrosis airway epithelial cells. Thorax (2012) 0.93
Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells. J Biol Chem (2008) 0.92
Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor κB and c-Jun N-terminal kinase activation. J Allergy Clin Immunol (2013) 0.92
Protein kinase R, IkappaB kinase-beta and NF-kappaB are required for human rhinovirus induced pro-inflammatory cytokine production in bronchial epithelial cells. Mol Immunol (2006) 0.91
An anti-human ICAM-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammation. PLoS Pathog (2013) 0.91
Rhinovirus infection induces expression of airway remodelling factors in vitro and in vivo. Respirology (2011) 0.91
Neonatal bronchial hyperresponsiveness precedes acute severe viral bronchiolitis in infants. J Allergy Clin Immunol (2012) 0.90
Gas cooking and smoking habits and the risk of childhood and adolescent wheeze. Am J Epidemiol (2005) 0.90
Inhaled glucocorticoids and COPD exacerbations. N Engl J Med (2015) 0.90
Genetics and epidemiology: asthma and infection. Curr Opin Allergy Clin Immunol (2009) 0.89
Rhinovirus infections and immunisation induce cross-serotype reactive antibodies to VP1. Antiviral Res (2012) 0.88
Obesity and susceptibility to severe outcomes following respiratory viral infection. Thorax (2013) 0.88
Genetic predisposition of RSV infection-related respiratory morbidity in preterm infants. Eur J Pediatr (2014) 0.88
Signalling pathways mediating type I interferon gene expression. Microbes Infect (2007) 0.88
Mechanisms and experimental models of chronic obstructive pulmonary disease exacerbations. Proc Am Thorac Soc (2005) 0.88
IL-1beta induces IL-8 in bronchial cells via NF-kappaB and NF-IL6 transcription factors and can be suppressed by glucocorticoids. Pulm Pharmacol Ther (2005) 0.88
Rhinovirus-induced basic fibroblast growth factor release mediates airway remodeling features. Clin Transl Allergy (2012) 0.87
Use of induced sputum for the diagnosis of influenza and infections in asthma: a comparison of diagnostic techniques. J Clin Virol (2003) 0.87
Mechanisms of rhinovirus-induced asthma. Paediatr Respir Rev (2004) 0.87
Respiratory outcome of prematurely born infants following human rhinovirus A and C infections. Eur J Pediatr (2014) 0.86
TLR3, TLR4 and TLRs7-9 Induced Interferons Are Not Impaired in Airway and Blood Cells in Well Controlled Asthma. PLoS One (2013) 0.86
Lung function of preterm infants before and after viral infections. Eur J Pediatr (2014) 0.86
Systemic tryptophan and kynurenine catabolite levels relate to severity of rhinovirus-induced asthma exacerbation: a prospective study with a parallel-group design. Thorax (2013) 0.84